Aprea Therapeutics, Inc.

NASDAQ: APRE · Healthcare · Biotechnology

PublicHQ Boston, MA · SuffolkCIK 0001781983Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 42DQ —GM —SS 33

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, filing timeliness · ↓ Piotroski F, workforce scale

Methodology →

Revenue TTM

$118.1k

Rev growth YoY (TTM)

-90.8%

Net income (FY)

-$12.6M

Employees

Market cap

$4.8M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$12.6M-$12.6M2025

Operating income-$13.2M-$13.2M2025

Total assets$15.9M$15.9M2025

Liabilities$3.2M$3.2M2022

Equity$12.4M$12.4M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Aprea Therapeutics, Inc. earned -$12.6M in FY2025 net income.

Peers · Healthcare

Imunon, Inc.38D Quince Therapeutics, Inc.——Tempest Therapeutics, Inc.26D PharmaCyte Biotech, Inc.61C

Neighbors

Suffolk →

Vertex Pharmaceuticals Incorporated$12.0B88A American Tower Corporation$935.9M75B+State Street Corporation$13.9B67B NSTAR Electric Company——Toast, Inc.$6.2B67B PTC Inc.$2.7B84B+

Key facts

CEOOren Gilad

SectorHealthcare

IndustryBiotechnology

HeadquartersBoston, MA

ExchangeNASDAQ: APRE

Employees8

IPO date2019-10-03

Latest filings

8-K2026-06-17 8-K2026-05-13 10-Q2026-05-13 DEF 14A2026-04-30 8-K2026-04-01 8-K2026-03-30 8-K2026-03-16 10-K2026-03-16

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.